Biotech Preliminary Results of Qilu Pharmaceutical’s Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting December 25, 2024
Biotech Neurocrine Biosciences, Inc. Selects PANTHERx®Rare Specialty Pharmacy for Distribution of Crenessity™ (crinecerfont) December 24, 2024
Biotech U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation’s GeoMx Products December 24, 2024
Biotech Luraco Technologies Unveils the Next Generation of Wellness: Introducing the Luraco Wellness Medical Massage Chairs December 20, 2024
Biotech Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing December 20, 2024
Biotech TargED Biopharmaceuticals doses first participant in Phase 1 clinical trial of TGD001, a groundbreaking thrombolytic in acute ischemic stroke (AIS) and TTP December 19, 2024